Deadline Soon: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz reminded investors that the deadline to seek lead plaintiff status in a securities fraud class action against Beta Bionics (NASDAQ: BBNX) is November 3, 2026, covering purchasers of BBNX securities between July 30, 2025 and February 24, 2026. The complaint alleges Beta Bionics made misleading statements about an FDA Form 483 that identified over 18,000 complaints, including life-threatening hypoglycemic events the company allegedly failed to investigate or report to the FDA.
Key figures
- Class period
- July 30, 2025 - February 24, 2026
- Jan 9 2026 close
- 20.14
- Feb 25 2026 close
- 12.89
- Jan 30 2026 close
- 13.83
- Jan 9 2026 decline pct
- 37.04%
- Feb 25 2026 decline pct
- 3.73%
- Jan 30 2026 decline pct
- 6.5%
- Lead plaintiff deadline
- November 3, 2026
- Fda form483 complaints alleged
- over 18,000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.